Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

YearNumber of Results
2001 1
2002 1
2003 1
2004 1
2006 2
2007 10
2008 25
2009 28
2010 37
2011 42
2012 48
2013 60
2014 66
2015 72
2016 88
2017 99
2018 106
2019 75
2020 91
2021 94
2022 98
2023 61
2024 29
2025 6

Search Results

978 results

Results by year

Filters applied: . Clear all
Page 1
Clearance systems in the brain-implications for Alzheimer disease.
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Ménard J, Zetterberg H, Wisniewski T, de Leon MJ.Tarasoff-Conway JM, et al.Nat Rev Neurol. 2015 Aug;11(8):457-70. doi: 10.1038/nrneurol.2015.119. Epub 2015 Jul 21.Nat Rev Neurol. 2015.PMID: 26195256Free PMC article.Review.
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature.
Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG.Nelson PT, et al.J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7.J Neuropathol Exp Neurol. 2012.PMID: 22487856Free PMC article.Review.
Alzheimer's disease: experimental models and reality.
Drummond E, Wisniewski T.Drummond E, et al.Acta Neuropathol. 2017 Feb;133(2):155-175. doi: 10.1007/s00401-016-1662-x. Epub 2016 Dec 26.Acta Neuropathol. 2017.PMID: 28025715Free PMC article.Review.
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease.
Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Dubois B, Dufouil C, Ellis KA, van der Flier WM, Glodzik L, van Harten AC, de Leon MJ, McHugh P, Mielke MM, Molinuevo JL, Mosconi L, Osorio RS, Perrotin A, Petersen RC, Rabin LA, Rami L, Reisberg B, Rentz DM, Sachdev PS, de la Sayette V, Saykin AJ, Scheltens P, Shulman MB, Slavin MJ, Sperling RA, Stewart R, Uspenskaya O, Vellas B, Visser PJ, Wagner M; Subjective Cognitive Decline Initiative (SCD-I) Working Group.Jessen F, et al.Alzheimers Dement. 2014 Nov;10(6):844-52. doi: 10.1016/j.jalz.2014.01.001. Epub 2014 May 3.Alzheimers Dement. 2014.PMID: 24798886Free PMC article.Review.
APOE-amyloid interaction: Therapeutic targets.
Wisniewski T, Drummond E.Wisniewski T, et al.Neurobiol Dis. 2020 May;138:104784. doi: 10.1016/j.nbd.2020.104784. Epub 2020 Feb 4.Neurobiol Dis. 2020.PMID: 32027932Free PMC article.Review.
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.
Willhite CC, Karyakina NA, Yokel RA, Yenugadhati N, Wisniewski TM, Arnold IM, Momoli F, Krewski D.Willhite CC, et al.Crit Rev Toxicol. 2014 Oct;44 Suppl 4(Suppl 4):1-80. doi: 10.3109/10408444.2014.934439.Crit Rev Toxicol. 2014.PMID: 25233067Free PMC article.Review.
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.
Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR; Bapineuzumab 301 and 302 Clinical Trial Investigators.Salloway S, et al.N Engl J Med. 2014 Jan 23;370(4):322-33. doi: 10.1056/NEJMoa1304839.N Engl J Med. 2014.PMID: 24450891Free PMC article.Clinical Trial.
978 results
close